11,390 Shares in Agilent Technologies, Inc. $A Bought by Lecap Asset Management Ltd.

Lecap Asset Management Ltd. acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 11,390 shares of the medical research company’s stock, valued at approximately $1,550,000.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Flynn Zito Capital Management LLC lifted its stake in Agilent Technologies by 3.2% in the third quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock valued at $290,000 after buying an additional 69 shares during the last quarter. Forum Financial Management LP lifted its stake in Agilent Technologies by 2.5% in the third quarter. Forum Financial Management LP now owns 2,921 shares of the medical research company’s stock valued at $375,000 after buying an additional 70 shares during the last quarter. Gabelli Funds LLC lifted its stake in Agilent Technologies by 1.1% in the third quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock valued at $850,000 after buying an additional 74 shares during the last quarter. Fiduciary Trust Co lifted its stake in Agilent Technologies by 1.6% in the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after buying an additional 77 shares during the last quarter. Finally, NorthCrest Asset Manangement LLC lifted its stake in Agilent Technologies by 1.6% in the fourth quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock valued at $726,000 after buying an additional 79 shares during the last quarter.

Wall Street Analyst Weigh In

A number of research firms have issued reports on A. Weiss Ratings reiterated a “hold (c+)” rating on shares of Agilent Technologies in a research note on Monday, December 29th. Evercore upgraded shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their price objective for the company from $155.00 to $160.00 in a research note on Monday, January 5th. Wells Fargo & Company cut their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. Morgan Stanley cut their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. Finally, TD Cowen cut their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Two analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $160.53.

Agilent Technologies Price Performance

Shares of NYSE A opened at $121.72 on Friday. Agilent Technologies, Inc. has a fifty-two week low of $99.12 and a fifty-two week high of $160.27. The firm’s 50-day simple moving average is $118.10 and its 200 day simple moving average is $133.92. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. The stock has a market cap of $34.40 billion, a P/E ratio of 26.87, a P/E/G ratio of 2.49 and a beta of 1.30.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. Agilent Technologies’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Equities analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, March 31st. Agilent Technologies’s payout ratio is presently 22.52%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.